BACKGROUND: Although xenotransplantation of vascularized organs/cells has not yet reached the clinic, glutaraldehyde-treated bioprosthetic heart valves (BHV), derived from porcine or bovine tissues, are today used for clinical replacement of diseased heart valves. However, the durability of these valve cusps is limited partly due to the onset of immune responses to the grafts. The xenoantigen-determinant Galα3Gal- and corresponding anti-Gal antibodies have been postulated to in part contribute to BHV damage. However, the presence of other non-Gal carbohydrate antigen determinants as well as the immune response to these non-Gal antigens and the inflammatory response generated by their interaction with the immune system has not been studied. In this study, we have isolated and structurally characterized both non-acid and acid glycosphingolipids from naïve porcine aortic and pulmonary valve cusps. METHODS: Total non-acid and acid glycosphingolipids were isolated from porcine aortic and pulmonalis valve cusps of 20 animals. Glycosphingolipid components were structurally characterized by thin-layer chromatography, liquid chromatography-mass spectrometry and binding of monoclonal antibodies and lectins. RESULTS: The non-acid glycosphingolipids were characterized as globotetraosylceramide, H-type 2 pentaosylceramide, fucosyl-gangliotetraosylceramide, and Galα3neolactotetraosylceramide. The acid glycosphingolipid fractions had both sulfatide and gangliosides (GM3, GM2, GM1, fucosyl-GM1, GD3 and GD1a), and all gangliosides contained N-acetyl-neuraminic acid. Significantly, the N-glycolyl-neuraminic acid (NeuGc) variant, a major component in many pig organs and to which humans can develop antibodies, was not detected among the gangliosides. CONCLUSIONS: Pig valve cusps contain several complex lipid-bound carbohydrate structures that may be targets for the human immune system. Notable, the NeuGc determinant was absent in the cusp gangliosides. This work forms a platform for further characterizing the antibody reactivity of patients with porcine-derived BHV.
BACKGROUND: Although xenotransplantation of vascularized organs/cells has not yet reached the clinic, glutaraldehyde-treated bioprosthetic heart valves (BHV), derived from porcine or bovine tissues, are today used for clinical replacement of diseased heart valves. However, the durability of these valve cusps is limited partly due to the onset of immune responses to the grafts. The xenoantigen-determinant Galα3Gal- and corresponding anti-Gal antibodies have been postulated to in part contribute to BHV damage. However, the presence of other non-Gal carbohydrate antigen determinants as well as the immune response to these non-Gal antigens and the inflammatory response generated by their interaction with the immune system has not been studied. In this study, we have isolated and structurally characterized both non-acid and acid glycosphingolipids from naïve porcine aortic and pulmonary valve cusps. METHODS: Total non-acid and acid glycosphingolipids were isolated from porcine aortic and pulmonalis valve cusps of 20 animals. Glycosphingolipid components were structurally characterized by thin-layer chromatography, liquid chromatography-mass spectrometry and binding of monoclonal antibodies and lectins. RESULTS: The non-acid glycosphingolipids were characterized as globotetraosylceramide, H-type 2 pentaosylceramide, fucosyl-gangliotetraosylceramide, and Galα3neolactotetraosylceramide. The acid glycosphingolipid fractions had both sulfatide and gangliosides (GM3, GM2, GM1, fucosyl-GM1, GD3 and GD1a), and all gangliosides contained N-acetyl-neuraminic acid. Significantly, the N-glycolyl-neuraminic acid (NeuGc) variant, a major component in many pig organs and to which humans can develop antibodies, was not detected among the gangliosides. CONCLUSIONS:Pig valve cusps contain several complex lipid-bound carbohydrate structures that may be targets for the human immune system. Notable, the NeuGc determinant was absent in the cusp gangliosides. This work forms a platform for further characterizing the antibody reactivity of patients with porcine-derived BHV.
Authors: Wendy F Li; Heidi Pollard; Mohsen Karimi; Jeremy D Asnes; William E Hellenbrand; Veronika Shabanova; Constance G Weismann Journal: Congenit Heart Dis Date: 2017-11-17 Impact factor: 2.007
Authors: Whayoung Lee; Yuko Miyagawa; Cassandra Long; Burcin Ekser; Eric Walters; Jagdeece Ramsoondar; David Ayares; A Joseph Tector; David K C Cooper; Hidetaka Hara Journal: Cornea Date: 2016-01 Impact factor: 2.651
Authors: Yoshihide Nanno; Eric Sterner; Jeffrey C Gildersleeve; Bernhard J Hering; Christopher Burlak Journal: Xenotransplantation Date: 2019-11-24 Impact factor: 3.788
Authors: Maria Elena Soto; Jose Luis Salas; Jesus Vargas-Barron; Ricardo Marquez; Alejandra Rodriguez-Hernandez; Rafael Bojalil-Parra; Israel Pérez-Torres; Veronica Guarner-Lans Journal: BMC Cardiovasc Disord Date: 2017-04-14 Impact factor: 2.298
Authors: Thomas Senage; Anu Paul; Thierry Le Tourneau; Imen Fellah-Hebia; Marta Vadori; Salam Bashir; Manuel Galiñanes; Tomaso Bottio; Gino Gerosa; Arturo Evangelista; Luigi P Badano; Alberto Nassi; Cristina Costa; Galli Cesare; Rizwan A Manji; Caroline Cueff de Monchy; Nicolas Piriou; Romain Capoulade; Jean-Michel Serfaty; Guillaume Guimbretière; Etienne Dantan; Alejandro Ruiz-Majoral; Guénola Coste du Fou; Shani Leviatan Ben-Arye; Liana Govani; Sharon Yehuda; Shirley Bachar Abramovitch; Ron Amon; Eliran Moshe Reuven; Yafit Atiya-Nasagi; Hai Yu; Laura Iop; Kelly Casós; Sebastián G Kuguel; Arnau Blasco-Lucas; Eduard Permanyer; Fabrizio Sbraga; Roger Llatjós; Gabriel Moreno-Gonzalez; Melchor Sánchez-Martínez; Michael E Breimer; Jan Holgersson; Susann Teneberg; Marta Pascual-Gilabert; Alfons Nonell-Canals; Yasuhiro Takeuchi; Xi Chen; Rafael Mañez; Jean-Christian Roussel; Jean-Paul Soulillou; Emanuele Cozzi; Vered Padler-Karavani Journal: Nat Med Date: 2022-02-17 Impact factor: 87.241